Aurobindo Pharma closes trading window for insiders ahead of Q2/H1 2026 results Back

<p>Aurobindo Pharma Limited informed the National Stock Exchange of India Limited and BSE Limited that the trading window for dealing in the company's securities will be closed for designated persons, including promoters, directors, and employees, from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the second quarter and half year ending September 30, 2026.</p>